Controlling the Redox Chemistry of Cobalt Radiopharmaceuticals

控制钴放射性药物的氧化还原化学

阅读:1

Abstract

The elementally matched (55)Co(2+/3+) (t(1/2)=17.53 h, I(β+)=77 %)/(58m)Co(2+/3+) (t(1/2)=9.10 h, internal conversion=100 %) radioisotope pair is of interest for development of paired diagnostic/therapeutic radiopharmaceuticals. Due to the accessibility of the (nat/55)Co(2+/3+) redox couple, the redox state can be readily modulated. Here, we show that macroscopic and radiochemical redox reactions can be closely monitored and controlled using spectroscopic and radiochemical methods. We employ model systems to inform how to selectively synthesize thermodynamically favored oxidation state coordination complexes. In addition to exogenous oxidants, our data indicates that (55)Co-induced radiolysis of water efficiently and directly drives selective oxidation to the (55)Co(3+) species under no-carrier added (n.c.a.) conditions. Our synthetic strategies subsequently stabilize the respective (55)Co(2+) or (55)Co(3+) species for targeted positron emission tomography imaging in a mouse tumor model.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。